Skip to main content
Prithvi Mruthyunjaya, MD, Ophthalmology, Stanford, CA

PrithviMruthyunjayaMD

Ophthalmology Stanford, CA

Retinal Disease, Ocular Oncology

Associate Professor of Ophthalmology, Byers Eye Institute at Stanford

Dr. Mruthyunjaya is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mruthyunjaya's full profile

Already have an account?

  • Office

    300 Pasteur Dr
    Stanford, CA 94305
    Phone+1 650-723-4000
    Fax+1 650-565-8297

Summary

  • Prithvi Mruthyunjaya MD, MHS is Associate Professor of Ophthalmology at Stanford Univeristy, member of the Vitreoretinal Surgery Service and is the new Director of Ocular Oncology at the Byers Eye Institute. At the Duke Eye Center in Durham, NC, he finished his Ophthalmology residency, Chief Residency, and clinical-research fellowships in Vitreoretinal surgery followed by an Ocular Oncology fellowship at the Moorfields Eye Hosptial in London, UK. He has been recognized by the Heed, AOS-Knapp and Ronald G Michels foundations. He was on faculty at Duke from 2005-16 where developed an integrated Retina-Ocular Oncology program and was named a tenured Associate Professor of Ophthalmology and Radiation Oncology, Medical Director and Director of Ocular Oncology.

    Dr. Mruthyunjaya’s clinical interest lies in the multi-disciplinary, vitreoretinal approach to ocular tumors and simulating conditions, and complex vitreoretinal disorders.. He manages both adult and pediatric ocular cancers with a focus on novel therapeutics, intraocular biopsy, and vision-saving strategies to reduce treatment toxicity. His academic contributions were recognized by the American Society of Retina Specialists with a Senior Honor Award. His passion lies in developing collaborative research networks and training the next generation of vitreoretinal surgeons.

Education & Training

  • Duke University Hospital
    Duke University HospitalResidency, Ophthalmology, 1997 - 2000
  • University of Rochester
    University of RochesterInternship, Internal Medicine, 1996 - 1997
  • Albany Medical College
    Albany Medical CollegeClass of 1996

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2016 - 2026
  • NC State Medical License
    NC State Medical License 1997 - 2025
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Fellow (FAAO) American Academy of Ophthalmology
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Publications & Presentations

PubMed

Journal Articles

  • Do Racial/Ethnic Disparities in Rates of Enucleation for Uveal Melanoma Indicate Poor Quality of Care or Financial Obstacles?—Reply  
    Prithvi Mruthyunjaya, MD, JAMA Ophthalmology
  • Questions on Rhegmatogenous Retinal Detachment and the Day of the Week of Repair or Diagnosis—Reply  
    Prithvi Mruthyunjaya, MD, JAMA Ophthalmology
  • Comparison of Optical Coherence Tomography with Fundus Photographs, Fluorescein Angiography, and Histopathologic Analysis in Assessing Coats Disease  
    Prithvi Mruthyunjaya, Cynthia A Toth, Sally S Ong, Lejla Vajzovic, JAMA

Press Mentions

  • Aura Biosciences Reports Third Quarter 2024 Financial Results and Business Highlights
    Aura Biosciences Reports Third Quarter 2024 Financial Results and Business HighlightsNovember 12th, 2024
  • Stanford University Study Finds Ovarian Cancer Drug Can Affect the Eyes
    Stanford University Study Finds Ovarian Cancer Drug Can Affect the EyesOctober 23rd, 2024
  • Rare Eye Cancer Is the Focus of 'Lookin' for a Cure' 5K Run
    Rare Eye Cancer Is the Focus of 'Lookin' for a Cure' 5K RunMay 17th, 2019

Professional Memberships